Therma Bright Enters into Securities for Services Agreement, Debt Settlement, and Issues Options
Toronto, Ontario--(Newsfile Corp. - August 12, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its...
Day: August 12, 2021
PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results
Conference call to be held today at 4:30 PM EDT NEW YORK--(BUSINESS WIRE)--$pavm--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or...
Movano Inc. Provides Business Update and Reports Second Quarter 2021 Financial Results
Conference call begins at 2:00 p.m. Pacific time todayPLEASANTON, CA / ACCESSWIRE / August 12, 2021 / Today, Movano Inc....
ENDRA Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update
Conference call begins at 4:30 p.m. Eastern time todayANN ARBOR, MI / ACCESSWIRE / August 12, 2021 / ENDRA Life...
Viveve Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Total revenue of $1.7M reported for Q2Reported sales of approximately 3,500 consumable treatment tips - a 42% unit increase quarter-over-quarterPivotal...
NOTICE TO DISREGARD — Marijuana Company of America, Inc.
LOS ANGELES, CA / ACCESSWIRE / August 12, 2021 / We are advised by Marijuana Company of America, Inc. that...
AlzeCure to Present Abstract at ECNP Conference on NeuroRestore Project’s Potential in Depression
STOCKHOLM, SWEDEN / ACCESSWIRE / August 12, 2021 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a...
Neuropathix, Inc. Appoints Michael Ropacki, PhD to the Company’s Scientific Advisory Board
DOYLESTOWN, PA / ACCESSWIRE / August 12, 2021 / Neuropathix, Inc. ("Neuropathix" or the "Company") (OTCQB:NPTX), a socially responsible pain...
9 Meters Biopharma Provides Business Update and Reports Financial Results for the Second Quarter 2021
- Initiated Phase 2 VIBRANT study of vurolenatide for short bowel syndrome (SBS) in Q2; total stool output (TSO) is...
Aptevo Therapeutics Reports Second Quarter Financial Results with Business Highlights
SEATTLE, WA / ACCESSWIRE / August 12, 2021 / Aptevo Therapeutics Inc. ("Aptevo" or "the Company") (NASDAQ:APVO), a clinical-stage biotechnology...
Biotricity to Report First Quarter Fiscal 2022 Financial Results on August 16, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 12, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology...
Lone Star Pharmaceuticals Joins the Council of Pharmacy Executives and Suppliers
Organization Serves to Foster Dialogue Between Healthcare Executives and Equipment SuppliersDALLAS, TX / ACCESSWIRE / August 12, 2021 / Lone...
Ovation Science Announces Expanded Distribution of DermSafe Hand Sanitizer
On-going Pandemic Has Raised Importance for Employers to Implement Preventive MeasuresVANCOUVER, BC and LAS VEGAS, NV / ACCESSWIRE / August...
Tarsus Pharmaceuticals, Inc. Appoints Pharmaceutical and Healthcare Industry Leader Rosemary A. Crane to Board of Directors
Ms. Crane brings over 30 years of experience in executive leadership, commercialization, and business development in the pharmaceutical and healthcare...
Sunshine Biopharma’s Coronavirus Treatment Anticipated to be Effective Against Delta and the Other Variants of Concern
MONTREAL, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC Pink: “SBFM”), a pharmaceutical company focused on the research,...
Zealand Pharma Launches ZEGALOGUE® (dasiglucagon) Injection and Advances Pipeline Programs Across Multiple Therapeutic Areas
Company annoucement - No. 50 / 2021 Interim report for H1 2021 Zealand Pharma Launches ZEGALOGUE® (dasiglucagon) Injection and Advances...
CooperCompanies Announces MiSight® Approval in China
SAN RAMON, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced that the Chinese National Medical Products...
Last Patient Last Visit Completed in Innovation Pharmaceuticals’ Phase 2 Clinical Trial of Brilacidin for COVID-19; Trial Database Undergoing Review in Preparation for Database Lock
WAKEFIELD, Mass., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today provided...
OliX Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for Investigational Hair Loss Therapeutic, OLX104C
SUWON, Republic of Korea, Aug. 12, 2021 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi...
Progyny, Inc. Offers Paid Pregnancy Loss Leave to its Employees
Fertility Benefits Company Enhances Bereavement Leave Policy to Explicitly Recognize the Physical, Emotional and Mental Health Impact of Pregnancy LossNew...